143 completed, 70 recruiting, 41 terminated, 36 unknown. 335 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 335 | Completed 143, Recruiting 70, Terminated 41, Unknown 36, Not yet recruiting 21, Active not recruiting 14, Withdrawn 6, Suspended 3, Enrolling by invitation 1 |
Follow Multiple Myeloma: new trials by email Literature Review of Multiple Myeloma trials Research Report on Multiple Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway - Multiple Myeloma, Heart Disease Risk Factors | Not applicable | Not yet recruiting | University of Vermont Medical Center | 33 | 2028-02-01 | 2026-08-25 |
| The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma Individual Exercise, Group Exercise - Multiple Myeloma | Not applicable | Suspended | Medical University of Vienna | 45 | 2027-09-01 | 2026-10-09 |
| Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) mHealth Intervention - Lung Cancer, Breast Cancer | Not applicable | Suspended | Ohio State University Comprehensive Cancer Center | 120 | 2026-11-15 | 2026-08-17 |
| Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) Mobile Cardiac Telemetry, Wearable Cardiac Monitor - Cardiotoxicity, Cancer | Not applicable | Not yet recruiting | University of Minnesota | 72 | 2026-10-29 | 2026-10-06 |
| Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System Subcutaneous Daratumumab Administration Using FreedomEDGE® - Multiple Myeloma or Amyloidosis | Not applicable | Not yet recruiting | Hospices Civils de Lyon | 100 | 2026-10-01 | 2026-07-23 |
| Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging ¹⁸F-florbetaben - Monoclonal Gammopathy, Monoclonal Gammopathy of Undetermined Significance (MGUS) | Not applicable | Not yet recruiting | University of Zurich | 50 | 2026-10-01 | 2026-06-03 |
| Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention Gustabor server, Standard Recommendations - Multiple Myeloma (MM), GI Cancer | Not applicable | Recruiting | Wuerzburg University Hospital | 198 | 2026-07-24 | 2026-08-20 |
| CD38 Targeted -PET/ CT for Multiple Myeloma standard-of-care imaging (FDG PET/CT), CD38 PET/CT - Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma | Not applicable | Recruiting | Guilin Medical University, China | 100 | 2026-07-07 | 2026-08-24 |
| PET-Enabled Dual-Energy CT in Multiple Myeloma PET-enabled dual-energy CT imaging, X-ray dual-energy CT imaging - Multiple Myeloma (MM) | Not applicable | Not yet recruiting | University of California, Davis | 45 | 2026-07-01 | 2026-06-15 |
| Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program - Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent | Not applicable | Completed | Selcuk University | 70 | 2026-07-01 | 2026-10-20 |
| Immune Fitness in Older Patients With Relapsed and Refractory Multiple Myeloma immunophenotyping of lymphocyte - Myeloma Multiple | Not applicable | Recruiting | Jules Bordet Institute | 31 | 2026-06-03 | 2026-06-29 |
| Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event TempTraq, VitalTraq - Cytokine Release Syndrome, Neoplasms | Not applicable | Enrolling by invitation | National Cancer Institute (NCI) | 136 | 2026-05-27 | 2026-06-25 |
| A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma Biospecimen Collection, Cognitive Intervention, Electronic Health Record Review - Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Multiple Myeloma | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 90 | 2026-04-28 | 2026-05-27 |
| Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial Thiotepa and Melphalan, Melphalan - Multiple Myeloma | Not applicable | Not yet recruiting | First Affiliated Hospital Xi'an Jiaotong University | 204 | 2026-04-20 | 2026-04-21 |
| Halt Aging in Survivors of Blood Cancers Behavioral Coaching Intervention, Virtual Exercise Platform - Hematological Malignancy, Leukemia | Not applicable | Recruiting | University of Nebraska | 180 | 2026-04-09 | 2026-07-01 |
| FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease Health Coaching, Prolonged Overnight Fasting (POF), Mediterranean Diet - Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance | Not applicable | Recruiting | University of Miami | 120 | 2026-04-07 | 2026-05-01 |
| Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations structured exercise training - Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma) | Not applicable | Recruiting | Kaohsiung Medical University Chung-Ho Memorial Hospital | 150 | 2026-03-12 | 2026-08-07 |
| Exercise Therapy for Multiple Myeloma Patients Orthopedic consultation and rehabilitation by excercise therapy - Multiple Myeloma Bone Lesions | Not applicable | Not yet recruiting | University Hospital Heidelberg | 71 | 2026-03-01 | 2026-02-04 |
| A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment Recurrent/refractory multiple myeloma (r/r MM) patients received infusion of BCMA-GPRC5D CAR-T cells - Multiple Myeloma | Not applicable | Not yet recruiting | Donghua Zhang | 28 | 2026-02-15 | 2026-01-29 |
| CAR-T Immunomonitoring in Multiple Myeloma (CART I5M) Additional Bone Marrow cells and blood sampling - Multiple Myeloma (MM) | Not applicable | Recruiting | Poitiers University Hospital | 60 | 2026-02-13 | 2026-02-18 |
Showing 20 of 335. Sign in to see all of them.
Lymphoma (77) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (63) · Lymphoma, Non-Hodgkin (62) · Hodgkin Disease (60) · Leukemia, Lymphocytic, Chronic, B-Cell (56) · Leukemia (55) · Leukemia, Myeloid, Acute (48) · Lymphoma, Mantle-Cell (46) · Lymphoma, Follicular (42) · Lymphoma, Large B-Cell, Diffuse (42) · Myelodysplastic Syndromes (41) · Neoplasms (41) · Myeloproliferative Disorders (40) · Burkitt Lymphoma (39)
Blood Protein Disorders (335) · Cardiovascular Diseases (335) · Hemic and Lymphatic Diseases (335) · Hemorrhagic Disorders (335) · Hemostatic Disorders (335) · Immune System Diseases (335) · Neoplasms by Histologic Type (335) · Vascular Diseases (335) · Immunoproliferative Disorders (334) · Hematologic Diseases (332) · Paraproteinemias (332) · Lymphoproliferative Disorders (326) · Neoplasms, Plasma Cell (302) · Neoplasms (294) · Lymphatic Diseases (133)
Cyclophosphamide (18) · fludarabine phosphate (14) · Peripheral Blood Stem Cell Transplantation (13) · Cyclosporine (12) · Whole-Body Irradiation (11) · Antilymphocyte Serum (10) · Busulfan (9) · Exercise (9) · fludarabine (9) · Blood Specimen Collection (8) · Dexamethasone (8) · Melphalan (8) · Mycophenolic Acid (8) · Filgrastim (7) · Acupuncture Therapy (6)
Fred Hutchinson Cancer Center (10) · M.D. Anderson Cancer Center (7) · Mayo Clinic (7) · Memorial Sloan Kettering Cancer Center (6) · Ohio State University Comprehensive Cancer Center (6) · Roswell Park Cancer Institute (6) · University of California, San Francisco (6) · Case Comprehensive Cancer Center (5) · Wake Forest University Health Sciences (5) · Washington University School of Medicine (5) · Assistance Publique - Hôpitaux de Paris (4) · Barbara Ann Karmanos Cancer Institute (4) · Bioray Laboratories (4) · City of Hope Medical Center (4) · Dana-Farber Cancer Institute (4)
United States (176) · China (39) · France (33) · Germany (11) · Canada (10) · Italy (7) · Belgium (6) · Denmark (6) · Brazil (4) · South Korea (4) · Turkey (Türkiye) (4) · United Kingdom (4) · Israel (3) · Poland (3) · Spain (3)
Rahul Banerjee, MD (4) · Jens Hillengass (3) · Charles A. Linker, MD (2) · Claudio Brunstein, MD (2) · David Maloney (2) · Fuling Zhou (2) · Gustavo Plaza-Manzano, PhD (2) · Nadine H. Abdallah, MD (2) · Paul Martin (2) · Urvi A Shah, MD, MS (2) · Wenming Chen, doctor (2) · A. John Barrett, M.D. (1) · Adam Binder, MD (1) · Adam Garsa, MD (1) · Aibin Liang, PhD (1)
PMID 32499241, PMID 16330788, PMID 18698002, PMID 20952514, PMID 21715313, PMID 21719601, PMID 21976674, PMID 22816680, PMID 23046417, PMID 23065508, PMID 23358983, PMID 23524640, PMID 24125911, PMID 24239343, PMID 24760791, PMID 25753814, PMID 26869630, PMID 27025228, PMID 28150872, PMID 28817727, PMID 28920142, PMID 29467138, PMID 29786478, PMID 31151984, PMID 31498394, PMID 31741745, PMID 32126972, PMID 32858582, PMID 33308307, PMID 33362896, PMID 34489267, PMID 34612832, PMID 34757221, PMID 34939484, PMID 35039279, PMID 35543814, PMID 36329525, PMID 36588407, PMID 36971688, PMID 37409464, PMID 37410541, PMID 37434730, PMID 37964424, PMID 38062808, PMID 38466984, PMID 38728244, PMID 38772898, PMID 38937310, PMID 39186588, PMID 39377681
P30CA015704 (4), P30CA033572 (4), P30CA138292 (3), 4UL1TR000427-10 (2), K01AT010488 (2), P01CA018029 (2), P30CA014520 (2), P30CA016672 (2), P30CA022453 (2), P30CA043703 (2), U2CCA252981 (2), UG1CA189823 (2), 2009 (1), 2019 (1), 2025 (1)